These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 18297688)

  • 41. Prognostic significance of beta-2 adrenergic receptor in oral squamous cell carcinoma.
    Bravo-Calderón DM; Oliveira DT; Marana AN; Nonogaki S; Carvalho AL; Kowalski LP
    Cancer Biomark; 2011-2012; 10(1):51-9. PubMed ID: 22297552
    [TBL] [Abstract][Full Text] [Related]  

  • 42. P-cadherin expression predicts clinical outcome in oral squamous cell carcinomas.
    Lo Muzio L; Pannone G; Mignogna MD; Staibano S; Mariggiò MA; Rubini C; Procaccini M; Dolci M; Bufo P; De Rosa G; Piattelli A
    Histol Histopathol; 2004 Oct; 19(4):1089-99. PubMed ID: 15375751
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prognostic role of p27(Kip1) expression in oral squamous cell carcinoma in Taiwan.
    Kuo MY; Hsu HY; Kok SH; Kuo RC; Yang H; Hahn LJ; Chiang CP
    Oral Oncol; 2002 Feb; 38(2):172-8. PubMed ID: 11854065
    [TBL] [Abstract][Full Text] [Related]  

  • 44. MUC4: a novel prognostic factor of oral squamous cell carcinoma.
    Hamada T; Wakamatsu T; Miyahara M; Nagata S; Nomura M; Kamikawa Y; Yamada N; Batra SK; Yonezawa S; Sugihara K
    Int J Cancer; 2012 Apr; 130(8):1768-76. PubMed ID: 21618516
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Immunocytochemical localization of fibroblast growth factor-1 (FGF-1) and FGF-2 in oral squamous cell carcinoma (SCC).
    Myoken Y; Myoken Y; Okamoto T; Sato JD; Takada K
    J Oral Pathol Med; 1994 Nov; 23(10):451-6. PubMed ID: 7532220
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Immunohistochemical Evaluation of GLUT-3 and GLUT-4 in Oral Epithelial Dysplasia and Oral Squamous Cell Carcinoma.
    Feitosa SG; Viana KF; Luna ECM; Costa FWG; Cavalcante RB; Chaves FN; Chaves HV; Pereira KMA
    Asian Pac J Cancer Prev; 2018 Jul; 19(7):1779-1783. PubMed ID: 30049187
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Expression form of p53 and PCNA at the invasive front in oral squamous cell carcinoma: correlation with clinicopathological features and prognosis.
    Kato K; Kawashiri S; Yoshizawa K; Kitahara H; Okamune A; Sugiura S; Noguchi N; Yamamoto E
    J Oral Pathol Med; 2011 Oct; 40(9):693-8. PubMed ID: 21501231
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prognostic value of activated Akt expression in oral squamous cell carcinoma.
    Lim J; Kim JH; Paeng JY; Kim MJ; Hong SD; Lee JI; Hong SP
    J Clin Pathol; 2005 Nov; 58(11):1199-205. PubMed ID: 16254112
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Expression of BCL10 is significantly associated with the progression and prognosis of oral squamous cell carcinomas in Taiwan.
    Chang HH; Kuo MY; Cheng SJ; Chiang CP
    Oral Oncol; 2009 Jul; 45(7):589-93. PubMed ID: 18952491
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prognostic implications of epidermal growth factor receptor immunoreactivity in squamous cell carcinoma of the oral mucosa.
    Maiorano E; Favia G; Maisonneuve P; Viale G
    J Pathol; 1998 Jun; 185(2):167-74. PubMed ID: 9713343
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Increased nuclear β-catenin expression in oral potentially malignant lesions: A marker of epithelial dysplasia.
    Reyes M; Rojas-Alcayaga G; Maturana A; Aitken JP; Rojas C; Ortega AV
    Med Oral Patol Oral Cir Bucal; 2015 Sep; 20(5):e540-6. PubMed ID: 26241451
    [TBL] [Abstract][Full Text] [Related]  

  • 52. High nuclear SOX2 expression is associated with radiotherapy response in small (T1/T2) oral squamous cell carcinoma.
    Attramadal CG; Halstensen TS; Dhakal HP; Ulekleiv CH; Boysen ME; Nesland JM; Bryne M
    J Oral Pathol Med; 2015 Aug; 44(7):515-22. PubMed ID: 25224722
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Enhancement of susceptibility to Fas-mediated apoptosis in oral squamous cell carcinoma cells by phosphatidylinositol 3-kinase inhibitor.
    Kondo G; Iwase M; Watanabe H; Uchida M; Takaoka S; Ohashi M; Nagumo M
    Oral Oncol; 2006 Aug; 42(7):745-52. PubMed ID: 16527514
    [TBL] [Abstract][Full Text] [Related]  

  • 54. p63 overexpression associates with poor prognosis in head and neck squamous cell carcinoma.
    Lo Muzio L; Santarelli A; Caltabiano R; Rubini C; Pieramici T; Trevisiol L; Carinci F; Leonardi R; De Lillo A; Lanzafame S; Bufo P; Piattelli A
    Hum Pathol; 2005 Feb; 36(2):187-94. PubMed ID: 15754296
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Fragile histidine triad expression in oral squamous cell carcinoma and precursor lesions.
    Kujan O; Oliver R; Roz L; Sozzi G; Ribeiro N; Woodwards R; Thakker N; Sloan P
    Clin Cancer Res; 2006 Nov; 12(22):6723-9. PubMed ID: 17121892
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Annexin A1 subcellular expression in laryngeal squamous cell carcinoma.
    Alves VA; Nonogaki S; Cury PM; Wünsch-Filho V; de Carvalho MB; Michaluart-Júnior P; Moyses RA; Curioni OA; Figueiredo DL; Scapulatempo-Neto C; Parra ER; Polachini GM; Silistino-Souza R; Oliani SM; Silva-Júnior WA; Nobrega FG; ; Tajara EH; Zago MA
    Histopathology; 2008 Dec; 53(6):715-27. PubMed ID: 19076685
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Reduction of p12DOC-1 expression is a negative prognostic indicator in patients with surgically resected oral squamous cell carcinoma.
    Shintani S; Mihara M; Terakado N; Nakahara Y; Matsumura T; Kohno Y; Ohyama H; McBride J; Kent R; Todd R; Tsuji T; Wong DT
    Clin Cancer Res; 2001 Sep; 7(9):2776-82. PubMed ID: 11555592
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prognostic Potential of N-Cadherin in Oral Squamous Cell Carcinoma via Immunohistochemical Methods.
    Chandolia B; Rajliwal JP; Bajpai M; Arora M
    J Coll Physicians Surg Pak; 2017 Aug; 27(8):475-478. PubMed ID: 28903838
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Nuclear heterogeneous nuclear ribonucleoprotein D is associated with poor prognosis and interactome analysis reveals its novel binding partners in oral cancer.
    Kumar M; Matta A; Masui O; Srivastava G; Kaur J; Thakar A; Shukla NK; RoyChoudhury A; Sharma M; Walfish PG; Michael Siu KW; Chauhan SS; Ralhan R
    J Transl Med; 2015 Aug; 13():285. PubMed ID: 26318153
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Biological significance of 5-hydroxymethylcytosine in oral epithelial dysplasia and oral squamous cell carcinoma.
    Cuevas-Nunez MC; Gomes CBF; Woo SB; Ramsey MR; Chen XL; Xu S; Xu T; Zhan Q; Murphy GF; Lian CG
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2018 Jan; 125(1):59-73.e2. PubMed ID: 28743666
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.